These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 316093)

  • 21. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
    Pranzatelli MR; Rubin G; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A quantitative rotational model for studying serotonergic function in the rat.
    Jacobs BL; Simon SM; Ruimy DD; Trulson ME
    Brain Res; 1977 Mar; 124(2):271-81. PubMed ID: 139194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective neurotoxic lesions of descending serotonergic and noradrenergic pathways in the rat.
    Berge OG; Fasmer OB; Tveiten L; Hole K
    J Neurochem; 1985 Apr; 44(4):1156-61. PubMed ID: 3919157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Selective lesions of serotonergic raphe neurons produced by 5,7-dihydroxytryptamine: effects on interspecific aggressive behavior in the rat].
    Vergnes M; Penot C; Kempf E; Mack G
    Brain Res; 1977 Sep; 133(1):167-71. PubMed ID: 561640
    [No Abstract]   [Full Text] [Related]  

  • 25. A general role for serotonin in the control of behavior: studies with intracerebral 5,7-dihydroxytryptamine.
    Vanderwolf CH
    Brain Res; 1989 Dec; 504(2):192-8. PubMed ID: 2598022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical denervation produces supersensitivity of central serotonergic receptors involved in the control of TSH secretion in the rat.
    Schettini G; Di Renzo G; Amoroso S; Annunziato L; Quattrone A
    Brain Res; 1983 Feb; 261(2):349-52. PubMed ID: 6831219
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of midbrain raphe lesion or 5,7-dihydroxytryptamine treatment on the prolactin-releasing action of quipazine and D-fenfluramine in rats.
    Quattrone A; Schettini G; di Renzo G; Tedeschi G; Preziosi P
    Brain Res; 1979 Sep; 174(1):71-9. PubMed ID: 487124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonergic denervation partially protects rat striatum from kainic acid toxicity.
    Berger M; Sperk G; Hornykiewicz O
    Nature; 1982 Sep; 299(5880):254-6. PubMed ID: 6213866
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of brain monoamine depletion on thermoregulatory responses of rabbits to different hypothalamic temperatures.
    Lin MT
    Exp Neurol; 1980 Nov; 70(2):226-35. PubMed ID: 7428893
    [No Abstract]   [Full Text] [Related]  

  • 30. Rotational behavior induced by unilateral electrical stimulations of nigro-striatal dopamine neurons: modification by low doses of apomorphine.
    Barghon R; Costentin JH
    Eur J Pharmacol; 1980 May; 64(1):39-46. PubMed ID: 6969658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of 5,7-dihydroxytryptamine and 6-hydroxydopamine on head-twitch response induced by serotonin, p-chloroamphetamine, and tryptamine in mice.
    Orikasa S; Sloley BD
    Psychopharmacology (Berl); 1988; 95(1):124-31. PubMed ID: 3133691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ascorbic acid does not modulate stimulated dopamine release: in vivo voltammetric data in the rat.
    Stamford JA; Kruk ZL; Millar J
    Neurosci Lett; 1985 Oct; 60(3):357-62. PubMed ID: 2999651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of p-chlorophenylalanine and 5,7-dihydroxytryptamine on feeding in rats.
    Hoebel BG; Zemlan FP; Trulson ME; MacKenzie RG; DuCret RP; Norelli C
    Ann N Y Acad Sci; 1978 Jun; 305():590-4. PubMed ID: 152082
    [No Abstract]   [Full Text] [Related]  

  • 34. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine.
    Currie PJ; Coscina DV; Fletcher PJ
    Brain Res; 1998 Jul; 800(1):62-8. PubMed ID: 9685586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations.
    Pranzatelli MR; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):67-76. PubMed ID: 3484993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential rotational behaviour after unilateral 5,7-dihydroxytryptamine induced lesions of the dorsal raphé nucleus [proceedings].
    Blackburn TP; Foster GA; Heapy CG; Kemp JD
    Br J Pharmacol; 1979 Nov; 67(3):431P-432P. PubMed ID: 574043
    [No Abstract]   [Full Text] [Related]  

  • 37. Control of dopamine release by dopamine receptors and by impulse flow as studied by in vivo voltammetry.
    Gonon FG
    Ann N Y Acad Sci; 1986; 473():160-9. PubMed ID: 3492168
    [No Abstract]   [Full Text] [Related]  

  • 38. Enhanced spatial discrimination learning in rats following 5,7-DHT-induced serotonergic deafferentation of the hippocampus.
    Altman HJ; Normile HJ; Galloway MP; Ramirez A; Azmitia EC
    Brain Res; 1990 Jun; 518(1-2):61-6. PubMed ID: 1697213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders.
    Winstanley CA; Theobald DE; Dalley JW; Robbins TW
    Neuropsychopharmacology; 2005 Apr; 30(4):669-82. PubMed ID: 15688093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5,7-Dihydroxytryptamine lesions of the ascending 5-hydroxytryptamine pathways: habituation, motor activity and agonistic behavior.
    Hole K; Johnson GE; Berge OG
    Pharmacol Biochem Behav; 1977 Sep; 7(3):205-10. PubMed ID: 563078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.